Skip to main content
Clinical Trials/NCT04343807
NCT04343807CompletedNot Applicable

Effectiveness of Ultrasound Guided PECS Block on Opioid Consumption and Patient Satisfaction Through Adequate Pain Control Following Breast Cancer Surgery. A Prospective Randomized Controlled Trial

Aga Khan University1 site in 1 country70 target enrollmentStarted: November 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
70
Locations
1
Primary Endpoint
Total intraoperative opioid consumption

Study Overview

Brief Summary

Breast cancer is the most common and leading cause of cancer deaths among females worldwide. Patients undergoing modified radical mastectomy (MRM) are associated with moderate to severe acute postoperative pain and shoulder mobility restriction.

This study aims to determine the effectiveness of ultrasound-guided PECS block for reducing opioid consumption, providing adequate postoperative pain management and improving patient satisfaction following breast cancer surgery.

Detailed Description

The traditional pain management for patients undergoing MRM has relied heavily on opioids but a number of multimodal pain control strategies also exist including combining opioids with NSAIDs, cyclooxygenase-2 inhibitors, acetaminophen and regional blocks. Recently, literature underlines the importance of performing regional anaesthetic and analgesic techniques for postoperative analgesia following breast surgery. PECS (Pectoral nerve block) block provides analgesia for breast surgeries with few adverse effects.

OBJECTIVES To evaluate the effect of ultrasound guided pectoral block in reducing intraoperative and postoperative opioid consumption following modified radical mastectomy.

The secondary objective is to determine patient satisfaction levels associated with adequate pain control.

HYPOTHESIS Pectoral nerve blocks provides superior analgesia with less opioid consumption and improves patient satisfaction in postoperative period compared to conventional pain management for modified radical mastectomy patients

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients undergoing elective modified radical mastectomy (MRM)
  • •All adults aged between 18 and 65 years
  • •ASA (American Society of Anesthesiologists ) I & II

Exclusion Criteria

  • •Patient refusal
  • •Hypersensitivity to local anaesthetics
  • •Coagulopathy or bleeding diathesis
  • •Local infection at the site of block
  • •BMI more than 35 kg/m2
  • •Chest wall deformity or previous breast surgery
  • •MRM with latissimus dorsi or deep inferior epigastric perforator flap reconstruction

Arms & Interventions

PECS block

Active Comparator

For patients in PECS group (PG), after induction of general anesthesia, the nerve block will be performed using the ultrasound-guided technique described by Blanco and colleagues. Block will be performed with a 22-gauge 100 mm needle (Stimuplex, B. Braun Medical Inc., Pennsylvania, USA) using Mindray M7 imaging system (Diagnostic Instruments Inc., China) with a high-frequency (6-13 MHz) linear array transducer.20 mL of ropivacaine 0.25% in 5-mL increments will be injected, aspirating gently between injections. The needle will be withdrawn to place the tip in the fascial plane between the pectoralis major and pectoralis minor muscles and ropivacaine 0.25%, 10 ml in 5 ml increments will be injected. Injectate spread between the muscles will be visualized. For patients in control group, no nerve block will be performed and only intravenous nalbuphine will be given.

Intervention: PECS Block (Procedure)

Control Group

Active Comparator

For patients in control group, after induction of general anesthesia, no nerve block will be performed and only intravenous nalbuphine will be given.

Intervention: Control Group (Other)

Outcomes

Primary Outcomes

Total intraoperative opioid consumption

Time Frame: During surgical procedure

Total intraoperative nalbuphine

Total postoperative opioid consumption

Time Frame: First 24 hours after surgery

Total Rescue Tramadol Consumption

Secondary Outcomes

  • Postoperative pain score(1, 6,12 and 24 hours after surgery)
  • Postoperative nausea and vomiting(First 24 hours after surgery)
  • Patient Satisfaction(First 24 hours after surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Faisal Shamim

Associate Professor Anaesthesiology

Aga Khan University

Study Sites (1)

Loading locations...

Similar Trials